Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: High expression of ULBP2 is an indicator of poor prognosis

Cancer Immunology, Immunotherapy

Volumn 58, Issue 5, 2009, Pages 641-652

  Li, Kui ^a,b   Mandai, Masaki ^a   Hamanishi, Junzo ^a   Matsumura, Noriomi ^a   Suzuki, Ayako ^a   Yagi, Haruhiko ^a   Yamaguchi, Ken ^a   Baba, Tsukasa ^a   Fujii, Shingo ^c   Konishi, Ikuo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b PEKING UNIVERSITY   (China)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

MICA B; NKG2D ligand; Ovarian cancer; Tumor immunology; ULBP2

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D;

ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER TISSUE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD57; CARCINOMA; CD8-POSITIVE T-LYMPHOCYTES; CULTURE MEDIA, CONDITIONED; DISEASE-FREE SURVIVAL; EPITHELIAL CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; KILLER CELLS, NATURAL; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; NEOPLASM PROTEINS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; OVARIAN NEOPLASMS; OVARY; PROGNOSIS;

EID: 61349167118     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0585-3     Document Type: Article

References (38)

1. S Bauer V Groh J Wu A Steinle JH Phillips LL Lanier T Spies 1999 Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA Science 285 727 729
2. A Busche T Goldmann U Naumann A Steinle S Brandau 2006 Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A Hum Gene Ther 17 135 146
3. JD Coudert L Scarpellino F Gros E Vivier W Held 2008 Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways Blood 111 7 3571 3578
4. H Das V Groh C Kuijl M Sugita CT Morita T Spies JF Bukowski 2001 MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function Immunity 15 83 93
5. A Diefenbach ER Jensen AM Jamieson DH Raulet 2001 Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity Nature 413 165 171
6. ES Doubrovina MM Doubrovin E Vider 2003 Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma J Immunol 171 6891 6899
7. G Eisele J Wischhusen M Mittelbronn R Meyermann I Waldhauer A Steinle M Weller MA Friese 2006 TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells Brain 129 Pt9 2416 2425
8. MA Friese M Platten SZ Lutz U Naumann S Aulwurm F Bischof HJ Buhring J Dichgans HG Rammensee A Steinle M Weller 2003 MICA/NKG2D mediated immunogene therapy of experimental gliomas Cancer Res 63 8996 9006
9. V Groh S Bahram S Bauer A Herman M Beauchamp T Spies 1996 Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium Proc Natl Acad Sci USA 93 12445 12450
10. V Groh A Steinle S Bauer T Spies 1998 Recognition of stress-induced MHC molecules by intestinal epithelial γδT cells Science 279 1737 1740
11. V Groh R Rhinehart H Secrist S Bauer KH Grabstein T Spies 1999 Broad tumor-associated expression and recognition by tumor-derived γδT cells of MICA and MICB Proc Natl Acad Sci USA 96 6879 6884
12. V Groh J Wu C Yee T Spies 2002 Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation Nature 419 734 738
13. J Hamanishi M Mandai M Iwasaki T Okazaki Y Tanaka K Yamaguchi T Higuchi H Yagi K Takakura N Minato T Honjo S Fujii 2007 Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer Proc Natl Acad Sci USA 104 3360 3365
14. Y Hayakawa JM Kelly JA Westwood PK Darcy A Diefenbach D Raulet MJ Smyth 2002 Cutting edge: tumor rejection mediated by NKG2D receptor ligand interaction is dependent upon perforin J Immunol 169 5377 5381
15. S Holdenrieder P Stieber A Peterfi D Nagel A Steinle RH Salih 2006 Soluble MICA in malignant diseases Int J Cancer 118 684 687
16. S Holdenrieder P Stieber A Peterfi D Nagel A Steinle RH Salih 2006 Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA Cancer Immunol Immunother 55 1284 1289
17. JY Hsia JT Chen CY Chen CP Hsu J Miaw YS Huang CY Yang 2005 Prognostic significance of intratumoral natural killer cells in primary resected esophageal squamous cell carcinoma Chang Gung Med J 28 335 340
18. JF Huang Y Yang H Sepulveda W Shi I Hwang PA Peterson MR Jackson J Sprent Z Cai 1999 TCR-Mediated internalization of peptide-MHC complexes acquired by T cells Science 286 952 954
19. S Ishigami S Natsugoe K Tokuda A Nakajo X Che H Iwashige K Aridome S Hokita T Aikou 2000 Prognostic value of intratumoral natural killer cells in gastric carcinoma Cancer 88 577 583
20. AM Jamieson A Diefenbach CW McMahon N Xiong JR Carlyle DH Raulet 2002 The role of the NKG2D immunoreceptor in immune cell activation and natural killing Immunity 17 19 29
21. LL Lanier 2001 A renaissance for the tumor immunosurveillance hypothesis Nat Med 7 1178 1180
22. C Maccalli D Pende C Castelli MC Mingari PF Robbins G Parmiani 2003 NKG2D engagement of colorectal cancer-specific T cells strengthens TCR mediated antigen stimulation and elicits TCR independent anti-tumor activity Eur J Immunol 33 2033 2043
23. FE McCann P Eissmann B Onfelt R Leung DM Davis 2007 The activating NKG2D ligand MHC class I-related chain A transfers from target cells to NK cells in a manner that allows functional consequences J Immunol 178 3418 3426
24. DE Oppenheim SJ Roberts SL Clarke 2005 Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance Nat Immunol 6 928 937
25. D Pende C Cantoni P Rivera M Vitale R Castriconi S Marcenaro M Nanni R Biassoni C Bottino A Moretta L Moretta 2001 Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin Eur J Immunol 31 1076 1086
26. D Pende P Rivera S Marcenaro CC Chang R Biassoni R Conte M Kubin D Cosman S Ferrone L Moretta A Moretta 2002 Major histocompatibility complex class I-related chainA and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D dependent natural killer cell cytotoxicity Cancer Res 62 6178 6186
27. DH Raulet 2003 Roles of the NKG2D immunoreceptor and its ligands Nat Rev Immunol 3 781 790
28. V Rebmann P Schutt D Brandhorst B Opalka T Moritz MR Nowrousian H Grosse-Wilde 2007 Soluble MICAs an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients Clin Immunol 123 114 120
29. P Roda-Navarro M Vales-Gomez SE Chisholm HT Reyburn 2006 Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function Proc Natl Acad Sci USA 103 11258 11263
30. HR Salih HG Rammensee A Steinle 2002 Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding J Immunol 169 4098 4102
31. HR Salih H Antropius F Gieseke SZ Lutz L Kanz HG Rammensee A Steinle 2003 Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia Blood 102 1389 1396
32. H Song JK Kim D Cosman I Choi 2006 Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression Cell Immunol 239 22 30
33. A Steinle V Groh T Spies 1998 Diversification, expression, and γδT cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules Proc Natl Acad Sci USA 95 12510 12515
34. CS Vetter W Lieb E-B Brocker JC Becker 2004 Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma Br J Cancer 91 1495 1499
35. FR Villegas S Coca VG Villarrubia R Jiménez MJ Chillón J Jareño M Zuil L Callol 2002 Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer Lung Cancer 35 23 28
36. I Waldhauer A Steinle 2006 Proteolytic release of soluble UL16-binding protein 2 from tumor cells Cancer Res 66 2520 2526
37. NF Watson I Spendlove Z Madjd R McGilvray AR Green IO Ellis JH Scholefield LG Durrant 2006 Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients Int J Cancer 118 1445 1452
38. K Wiemann HW Mittrücker U Feger SA Welte WM Yokoyama T Spies HG Rammensee A Steinle 2005 Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo J Immunol 175 720 729